Related Experiment Video
Updated: Jun 7, 2026
08:17
Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
Published on: September 27, 2018
Sacral neuromodulation stimulation in fecal incontinence
1Department of Colon and Rectal Surgery, Lerner College of Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. Hullt@ccf.org
International Urogynecology Journal
|October 26, 2010
Summary
Fecal incontinence (FI) is a common issue with varied treatments. Sacral nerve stimulation (SNS) shows promise, appearing superior to standard care and artificial bowel sphincters for managing FI.
Area of Science:
- Gastroenterology and Urology
- Neuromodulation therapies
Background:
- Fecal incontinence (FI) presents a significant clinical challenge with no universally optimal treatment.
- Existing interventions for FI have limitations in efficacy and patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of sacral nerve stimulation (SNS) as a treatment for fecal incontinence.
- To compare SNS with established treatments for FI, including medical management and artificial bowel sphincter implantation.
Main Methods:
- The study assessed sacral nerve stimulation (SNS) for fecal incontinence (FI).
- Direct comparisons were made between SNS, standard medical treatments, and artificial bowel sphincter (ABS) implantation.
Main Results:
- Sacral nerve stimulation (SNS) demonstrated overall superiority compared to standard medical treatment for FI.
- SNS also appeared more effective than the artificial bowel sphincter (ABS) in direct comparative assessments.
- The therapy has shown success in international clinical settings.
Conclusions:
- Sacral nerve stimulation (SNS) represents a promising therapeutic option for fecal incontinence (FI).
- Further evaluation and potential adoption in the United States are anticipated, pending FDA approval.
